http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130016224-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2011-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a1cc2c39215e293ab2d33368d82db00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d36e8be5dd90f20fba87445a0437862 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f4aa8adc194decd972b28544af62e6c |
| publicationDate | 2013-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20130016224-A |
| titleOfInvention | How to improve the dissolution of anticoagulant |
| abstract | A pharmaceutical composition containing a compound represented by formula (I), a pharmaceutically acceptable salt thereof, or a solvate thereof, which exhibits the inhibitory action of activated blood coagulation factor X and is useful as a prophylactic and / or therapeutic agent for thrombotic diseases, with good elution. The provision of the pharmaceutical composition which shows sex is calculated | required. According to the present invention, at least one excipient, disintegrating agent and binder selected from the group consisting of a compound represented by formula (I), a pharmaceutically acceptable salt thereof or solvates thereof, sugar alcohols and water swellable additives are granulated ( The manufacturing method of the pharmaceutical composition containing the compound represented by Formula (I) containing the process of mixing on the conditions which hold | maintain the maximum moisture value of the granulated material in i) at 10% or less is provided. |
| priorityDate | 2010-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.